3.15
1.29%
+0.04
Bullfrog AI Holdings Inc stock is currently priced at $3.15, with a 24-hour trading volume of 22,000.
It has seen a +1.29% increased in the last 24 hours and a -1.56% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $3.11 pivot point. If it approaches the $3.17 resistance level, significant changes may occur.
Previous Close:
$3.11
Open:
$3.08
24h Volume:
22,000
Market Cap:
$24.45M
Revenue:
-
Net Income/Loss:
$-5.36M
P/E Ratio:
-4.1037
EPS:
-0.7676
Net Cash Flow:
$-6.00M
1W Performance:
+8.25%
1M Performance:
-1.56%
6M Performance:
+9.38%
1Y Performance:
-37.38%
Bullfrog AI Holdings Inc Stock (BFRG) Company Profile
Name
Bullfrog AI Holdings Inc
Sector
Industry
Phone
240 658 6710
Address
325 Ellington Blvd, Unit 317, Gaithersburg
Bullfrog AI Holdings Inc Stock (BFRG) Latest News
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
GlobeNewswire Inc.
BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock
GlobeNewswire Inc.
BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip
GlobeNewswire Inc.
BullFrog AI Announces Closing of $5.7 Million Public Offering
GlobeNewswire Inc.
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Bullfrog AI Announces Pricing of $5.7 Million Public Offering
GlobeNewswire Inc.
Bullfrog AI Holdings Inc Stock (BFRG) Financials Data
Bullfrog AI Holdings Inc (BFRG) Net Income 2024
BFRG net income (TTM) was -$5.36 million for the quarter ending December 31, 2023, a -91.11% decrease year-over-year.
Bullfrog AI Holdings Inc (BFRG) Cash Flow 2024
BFRG recorded a free cash flow (TTM) of -$6.00 million for the quarter ending December 31, 2023, a -558.83% decrease year-over-year.
Bullfrog AI Holdings Inc (BFRG) Earnings per Share 2024
BFRG earnings per share (TTM) was -$0.89 for the quarter ending December 31, 2023, a -76.80% decline year-over-year.
About Bullfrog AI Holdings Inc
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
Cap:
|
Volume (24h):